Branded, generic and identical medicines – how much should you pay?

jaynelawrenceby Professor Jayne Lawrence, RPS Chief Scientist

Increasingly the public are being encouraged by the Government to take greater responsibility for their own health. In particular, they are being prompted to manage any minor and self-limiting medical condition themselves, which may result in the purchase of an over-the-counter (OTC) medicine.

While it is well recognised that a generic version of a medicine is cheaper than the original branded product, the reasons behind a patient choosing the branded or generic version are complex – in addition to medicine cost, other factors such as advertising, brand loyalty, product packaging or a perception of higher quality can all play a part in the decision a patient makes when purchasing a medicine. Read more Branded, generic and identical medicines – how much should you pay?

Pharmacists and Clinical Trials

By Professor Jayne Lawrence, Chief Scientist, Royal Pharmaceutical Society and Dr Rachel Joynes, Head of Research and Evaluation  

Today is International Clinical Trials Day (ICTD). Now in its 11th year, ICTD is celebrated around the world to commemorate the day James Lind started his famous clinical trial on scurvy. The day is an opportunity for organisations and clinical research professionals to discuss the benefits that involvement and engagement in research can bring. But what role do pharmacists play in clinical trials? And what opportunities are there to engage?  Read more Pharmacists and Clinical Trials

Branded versus generic medicines: is there any difference?

By Colin Cable, Pharmaceutical Science Information Adviser

Medicines have undoubtedly made a huge difference to the lives of millions of people.

But why do some medicines have more than one name? Read more Branded versus generic medicines: is there any difference?